Coronary artery calcium score could help guide aspirin therapy

Coronary artery calcium score could help guide aspirin therapy

(HealthDay)—For those who have an elevated coronary artery calcium (CAC) score, aspirin therapy may be beneficial for primary prevention of coronary heart disease (CHD), according to research published online May 6 in Circulation: Cardiovascular Quality and Outcomes.

Michael D. Miedema, M.D., M.P.H., of Harvard Medical School in Boston, and colleagues analyzed data for 4,229 participants from the Multi-Ethnic Study of Atherosclerosis to assess the use of CAC scores as a guide to selecting aspirin therapy for of CHD.

The researchers found that individuals with a CAC score of 100 or greater had an estimated net benefit for use of aspirin regardless of 10-year CHD Framingham Risk Score (FRS) (estimated five-year number needed to treat, 173 for <10 percent FRS and 92 for ≥10 percent FRS; estimated five-year number to harm of 442 for a major bleed). In contrast, individuals with a CAC score of zero had unfavorable estimations for use of to prevent CHD (estimated five-year number needed to treat, 2,036 for <10 percent FRS and 808 for ≥10 percent FRS; estimated five-year number to harm of 442 for a major bleed).

"For the primary prevention of , Multi-Ethnic Study of Atherosclerosis participants with CAC ≥100 had favorable risk/benefit estimations for aspirin use while participants with zero CAC were estimated to receive net harm from aspirin," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Coronary artery calcium predicts cardio death in T2DM

Jan 18, 2013

(HealthDay)—In addition to traditional cardiovascular disease risk factors, in patients with type 2 diabetes, coronary artery calcium (CAC) predicts the risk of cardiovascular death, according to a study ...

Recommended for you

Time to take notice and tackle heart failure

4 hours ago

Experts have sounded a call to action for policy makers at local, national, and international levels to promote heart failure prevention, improve heart failure awareness among healthcare professionals, ensure ...

Hopes dashed for an agent to prevent reperfusion injury

7 hours ago

The administration of an experimental agent known as TRO40303 to patients who have had a heart attack, with the hope of preventing tissue damage when impaired blood flow is corrected (reperfusion), was disappointingly ineffective ...

User comments